(Q45747425)

English

Complete cure of established murine hepatocellular carcinoma is achievable by repeated injections of retroviruses carrying the herpes simplex virus thymidine kinase gene

scientific article published in April 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

Complete cure of established murine hepatocellular carcinoma is achievable by repeated injections of retroviruses carrying the herpes simplex virus thymidine kinase gene (English)

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

author name string

Kuriyama S

1

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

Masui K

2

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

Kikukawa M

3

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

Sakamoto T

4

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

Nakatani T

5

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

Nagao S

6

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

Yamazaki M

7

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

Yoshiji H

8

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

Tsujinoue H

9

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

Fukui H

10

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

Yoshimatsu T

11

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

Ikenaka K

12

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

publication date

1 April 1999

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

6

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

4

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

525-533

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

https://scigraph.springernature.com/pub.10.1038/sj.gt.3300869

0 references

Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: Evidence from Southern Africa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Treatment of hepatocellular carcinoma: too many options?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Metabolic suicide genes in gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Transfer of genes to humans: early lessons and obstacles to success

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Gene therapy in the United States: a five-year status report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

High-efficiency retrovirus-mediated gene transfer into the livers of mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Construction of retroviral vectors to induce strong hepatoma cell-specific expression of cytokine genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Targeted killing of migrating glioma cells by injection of HTK-modified glioma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Establishment of parameters for optimal transduction efficiency and antitumor effects with purified high-titer HSV-TK retroviral vector in established solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Improvement of retroviral packaging cell lines by introducing the polyomavirus early region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Transformed cell lines susceptible or resistant to in vivo surveillance against tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

21 January 2018

Medical treatment of hepatocellular carcinoma: any progress?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

7 January 2021

based on heuristic

inferred from DOI database lookup

Transient immunosuppression with deoxyspergualin improves longevity of transgene expression and ability to readminister adenoviral vector to the mouse lung

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

7 January 2021

based on heuristic

inferred from DOI database lookup

A Potential Approach for Gene Therapy Targeting Hepatoma Using a Liver-Specific Promoter on a Retroviral Vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue-specific expression of HSV-tk gene can induce efficient antitumor effect and protective immunity to wild-type hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300869

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3300869

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10476212

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45747425&oldid=2079998543"